Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1084430

registered interest
date	08/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Department of Health and Social Care: Chief Scientific Advisers
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many meetings he held with his Department’s Chief Scientific Adviser between 1 December 2018 and 28 February 2019.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	230043
answer	answer is ministerial correction date of answer 14/03/2019 answer text <p>For the period 1 December 2018 and 28 February 2019, my Rt. hon. Friend the Secretary of State for Health and Social Care met with the Department’s Chief Scientific Adviser (CSA) seven times, and the CSA met with other Health and Social Care ministers on 12 occasions.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 14/03/2019 10:50:16 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1439 label Biography information for Norman Lamb

1082317

registered interest
date	05/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS Trusts: Legal Costs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much each NHS trust spent on legal fees defending employment tribunal cases relating to (a) discrimination, (b) unfair dismissal and (c) public interest disclosure in each year since 2016.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	228644
answer	answer is ministerial correction date of answer 12/03/2019 answer text <p>Costs for how much each National Health Service trust spent in legal fees defending employment tribunal cares relating to discrimination, unfair dismissal and public interest disclosure since 2016 is not held centrally.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 12/03/2019 12:42:06 answering member 1585 label Biography information for Stephen Hammond
tabling member	1439 label Biography information for Norman Lamb

1063732

registered interest
date	18/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	East of England Ambulance Service NHS Trust: Dismissal
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much has been spent by East of England Ambulance Service NHS Trust on (a) legal fees and (b) other costs associated with terminating the employment of Gordon Fleming and defending legal action brought by him.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	222781
answer	answer is ministerial correction date of answer 21/02/2019 answer text <p>The total legal costs incurred by the East of England Ambulance Service NHS Trust, since 2014, in respect of all matters, proceedings and appeals involving Mr Gordon Fleming is £252,162.15 plus VAT. This figure includes disbursements and Counsel’s fees. The Trust is unable to quantify other costs.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 21/02/2019 16:53:33 answering member 1585 label Biography information for Stephen Hammond
tabling member	1439 label Biography information for Norman Lamb

1061086

registered interest
date	14/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what process NICE will use to scope for the review of the NICE appraisal methodology; and whether the issue of combination treatments will be considered within scope.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	221614
answer	answer is ministerial correction date of answer 19/02/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) is in the process of planning how to conduct its scoping of the review of the methods for technology appraisal and highly specialised technologies evaluations. Scoping will involve industry and other relevant stakeholders, including patient organisations. Additional detail and more information will be made available on the NICE website in due course.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/02/2019 17:24:51 answering member 4067 label Biography information for Steve Brine
tabling member	1439 label Biography information for Norman Lamb

1054755

registered interest
date	04/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has received representations on patient anxieties about access to medicines including for epilepsy and depression; and what plans the Government has for communication on the availability of such medicines.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	216146
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>Medicines shortages are an ongoing issue that the Department manages constantly. The Department receives a wide range of representations regarding the availability of medicines on a regular basis.</p><p> </p><p>The Department’s Medicines Supply Team has well established procedures to deal with medicine shortages and works closely with all stakeholders to help prevent shortages and to ensure that the risks to patients are minimised when they do arise.</p><p> </p><p>Every shortage is different. The decision to communicate, and type of communication, will depend on a number of factors. We work closely with all stakeholders in these situations to provide advice on management options and to consider how best to communicate a supply problem to those affected. Where necessary, we will engage with relevant patient groups regarding specific medicine shortages, including, for example, several epilepsy patient groups.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 17:29:16 answering member 4067 label Biography information for Steve Brine
tabling member	1439 label Biography information for Norman Lamb

1045947

registered interest
date	22/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the merits of funding the free influenza vaccine for social care staff.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	211142
answer	answer is ministerial correction date of answer 28/01/2019 answer text <p>Flu vaccination of social care workers is recommended to protect staff, protect vulnerable users and to contribute to resilience of the health and social care system in the winter, including prevention of outbreaks in care homes.</p><p> </p><p>In October 2017, NHS England announced additional funding to support vaccination of frontline social care staff working in residential and care homes and in the community and offering direct care to vulnerable people. The 2017/18 NHS seasonal flu programme offered by general practices and community pharmacy was extended to include frontline social care staff. This was continued in 2018/19 and extended to frontline health and care staff working in the voluntary managed hospice sector. This scheme is intended to complement, not replace, any established occupational health schemes that employers have in place to offer the flu vaccination to their workforce.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 28/01/2019 17:08:11 answering member 4067 label Biography information for Steve Brine
tabling member	1439 label Biography information for Norman Lamb

1045948

registered interest
date	22/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the merits of monitoring influenza vaccination uptake among social care staff.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	211143
answer	answer is ministerial correction date of answer 28/01/2019 answer text <p>Frontline social care workers should be provided with influenza vaccine by their employer, with some staff able to access vaccination from their general practitioner or community pharmacy in a scheme funded by NHS England. Collecting comprehensive uptake data at a national level would be challenging. Most social care organisations do not have appropriate systems in place either to deliver influenza vaccine or collect uptake information and there are a large number of organisations, many independent, in the sector.</p><p> </p><p>In 2016/17, Public Health England undertook a pilot data collection in a sample of 320 care homes across England with a response rate of 51%. 70% of responding care homes do not have systems in place to collect data on staff influenza vaccination. In addition, only 38% of the responding care homes in the study sample provided data on vaccine uptake despite considerable local follow-up.</p><p> </p><p>For the 2018/19 season, NHS England is collecting data on the number of social care workers that access vaccination through the scheme they fund for some staff.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 28/01/2019 17:19:13 answering member 4067 label Biography information for Steve Brine
tabling member	1439 label Biography information for Norman Lamb

1038993

registered interest
date	10/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Members: Correspondence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to respond to the letter from the right hon. Member for North Norfolk of 26 July 2018 in relation to Dr Chris Day.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	207165
answer	answer is ministerial correction date of answer 15/01/2019 answer text <p>The Department has received both letters regarding Dr Chris Day from the Rt. hon. Member for North Norfolk and the hon. Member for Ellesmore Port and Neston dated 26 July 2018 and 17 December 2018. Officials are carefully considering their contents and preparing responses and my Rt. Hon. Friend the Secretary of State will be responding to the hon. Members’ letters shortly.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 207179 question first answered 15/01/2019 14:10:52 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1439 label Biography information for Norman Lamb

1038998

registered interest
date	10/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Members: Correspondence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to respond to the letter from the right hon. Member for North Norfolk and the hon. Member for Ellesmore Port and Neston of 17 December 2018, in relation to Dr Chris Day.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	207179
answer	answer is ministerial correction date of answer 15/01/2019 answer text <p>The Department has received both letters regarding Dr Chris Day from the Rt. hon. Member for North Norfolk and the hon. Member for Ellesmore Port and Neston dated 26 July 2018 and 17 December 2018. Officials are carefully considering their contents and preparing responses and my Rt. Hon. Friend the Secretary of State will be responding to the hon. Members’ letters shortly.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 207165 question first answered 15/01/2019 14:10:52 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1439 label Biography information for Norman Lamb

1039001

registered interest
date	10/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Epilepsy: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the availability of essential epilepsy medicines imported from the EU in the event that the UK leaves the EU without a deal; and if he will make a statement.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	207180
answer	answer is ministerial correction date of answer 15/01/2019 answer text <p>We understand that epilepsy medicines are vitally important to many people in this country. Our contingency plans aim to ensure that the supply of epilepsy medicines and other essential medicines to patients is not disrupted in all European Union exit scenarios, including a ‘no deal’ exit.</p><p> </p><p>That is why on 23 August 2018, the Department wrote to all pharmaceutical companies that supply prescription only medicines and pharmacy medicines to the United Kingdom that come from, or via, the EU or European Economic Area (EEA) asking them to ensure a minimum of six weeks additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019.</p><p> </p><p>We followed that up on 7 December 2018 when the Department wrote to pharmaceutical companies that supply licensed medicines to the UK from or via the EU/EEA, and/or manufacture medicines in the UK, informing them of the updated reasonable worst-case scenario border planning assumptions and asking them about their current transportation routes and their ability to re-route their supply chains if they currently rely on Dover and/or Folkestone.</p><p> </p><p>In response to those communications we have received very good engagement from industry, including companies supplying epilepsy medicines to the UK, who share our aims of ensuring continuity of medicines supply for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ EU exit.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 15/01/2019 15:53:16 answering member 1585 label Biography information for Stephen Hammond
tabling member	1439 label Biography information for Norman Lamb